The metabolic syndrome constellation (E88.81) abdominal obesity, hypertriglyceridemia, low HDL, hypertension, and elevated fasting glucose frequently co-occurs with obesity and compounds cardiovascular risk
Coverage depends on your state and whether it has chosen to cover obesity drugs
What About High-Risk Medications
After the initial 6 months, continued monthly visits are covered only if the patient achieved a 3 kg (6.6 lb) weight loss in the first 6 months
In UK practice, code the clinical manifestation first (e.g., R11.0 for nausea), followed by Y42.3 (Insulin and oral hypoglycaemic drugs causing adverse effects in therapeutic use) as the secondary external cause code
Documentation Summary for CDI Obesity Encounter Checklist For additional guidance on obesity coding, refer to the FY2026 ICD-10-CM Official Guidelines (CMS), the AHA Coding Clinic, and the American Society for Metabolic and Bariatric Surgery (ASMBS) clinical guidelines